A. KÖKEN AVŞAR Et Al. , "Tofacitinib therapy for severe pyoderma gangrenosum in a patient with enteropathic arthritis: a case-based review," Rheumatology International , vol.44, no.10, pp.2227-2237, 2024
KÖKEN AVŞAR, A. Et Al. 2024. Tofacitinib therapy for severe pyoderma gangrenosum in a patient with enteropathic arthritis: a case-based review. Rheumatology International , vol.44, no.10 , 2227-2237.
KÖKEN AVŞAR, A., DEMİRCİ YILDIRIM, T., & SARI, İ., (2024). Tofacitinib therapy for severe pyoderma gangrenosum in a patient with enteropathic arthritis: a case-based review. Rheumatology International , vol.44, no.10, 2227-2237.
KÖKEN AVŞAR, AYDAN, TUBA DEMİRCİ YILDIRIM, And İSMAİL SARI. "Tofacitinib therapy for severe pyoderma gangrenosum in a patient with enteropathic arthritis: a case-based review," Rheumatology International , vol.44, no.10, 2227-2237, 2024
KÖKEN AVŞAR, AYDAN K. Et Al. "Tofacitinib therapy for severe pyoderma gangrenosum in a patient with enteropathic arthritis: a case-based review." Rheumatology International , vol.44, no.10, pp.2227-2237, 2024
KÖKEN AVŞAR, A. DEMİRCİ YILDIRIM, T. And SARI, İ. (2024) . "Tofacitinib therapy for severe pyoderma gangrenosum in a patient with enteropathic arthritis: a case-based review." Rheumatology International , vol.44, no.10, pp.2227-2237.
@article{article, author={AYDAN KÖKEN AVŞAR Et Al. }, title={Tofacitinib therapy for severe pyoderma gangrenosum in a patient with enteropathic arthritis: a case-based review}, journal={Rheumatology International}, year=2024, pages={2227-2237} }